Genomictree Inc. (KOSDAQ:228760)
South Korea · Delayed Price · Currency is KRW 28,100
+300 (1.08%)
Dec 10, 2025, 3:30 PM KST
Genomictree Market Cap
Genomictree has a market cap or net worth of 675.03 billion as of December 10, 2025. Its market cap has increased by 78.71% in one year.
Market Cap
675.03B
Enterprise Value
592.20B
Revenue
3.76B
Ranking
n/a
PE Ratio
n/a
Stock Price
28,100.00
Market Cap Chart
Since April 5, 2017, Genomictree's market cap has increased from 59.00B to 675.03B, an increase of 1,044.14%. That is a compound annual growth rate of 32.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 9, 2025 | 667.82B | 36.12% |
| Dec 30, 2024 | 490.60B | 0.78% |
| Dec 28, 2023 | 486.82B | 168.25% |
| Dec 29, 2022 | 181.48B | -32.87% |
| Dec 30, 2021 | 270.36B | -7.66% |
| Dec 30, 2020 | 292.80B | -37.53% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 5, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 75.41T |
| Celltrion | 40.94T |
| ALTEOGEN | 24.49T |
| ABL Bio | 10.51T |
| SK Biopharmaceuticals | 10.44T |
| Yuhan | 8.66T |
| LigaChem Biosciences | 6.75T |
| HLB Co., Ltd. | 6.53T |